SCHEMBL20008685

SCHEMBL20008685

CN(C)C(=O)Cc1ccc(OC(=O)c2ccc(C(=N)N)cc2)cc1CC(C)(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TMPRSS15 P98073 13/20 0.41
PRSS1 P07477 6/20 0.41
TMPRSS2 O15393 2/20 0.41
F2 P00734 2/20 0.41
HPN P05981 2/20 0.41
KLK1 P06870 2/20 0.41
ADRA1A P35348 2/20 0.41
HGFAC Q04756 2/20 0.41
KCNH2 Q12809 2/20 0.41
MLNR O43193 1/20 0.41
ALDH1A1 P00352 1/20 0.41
C1R P00736 1/20 0.41
F10 P00742 1/20 0.41
PLG P00747 1/20 0.41
F12 P00748 1/20 0.41
LMNA P02545 1/20 0.41
ITGB3 P05106 1/20 0.41
CHRM2 P08172 1/20 0.41
ITGA2B P08514 1/20 0.41
C1S P09871 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20008690 0.90 PRSS1 (0.51) TMPRSS15PRSS1TMPRSS2F2HPN
SCHEMBL20008677 0.89 KMT2A (0.39) TMPRSS15PRSS1TMPRSS2F2HPN
SCHEMBL20008686 0.88 TMPRSS15 (0.47) TMPRSS15PRSS1TMPRSS2F2HPN
SCHEMBL20008692 0.80 F10 (0.39) TMPRSS15PRSS1TMPRSS2F2HPN
SCHEMBL20008665 0.80 PRSS1 (0.47) TMPRSS15PRSS1TMPRSS2F2HPN
SCHEMBL20008693 0.78 PRSS1 (0.42) TMPRSS15PRSS1TMPRSS2F2HPN
SCHEMBL20008687 0.78 PRSS1 (0.44) TMPRSS15PRSS1TMPRSS2F2HPN
SCHEMBL20008670 0.77 PRSS1 (0.44) TMPRSS15PRSS1TMPRSS2KLK1F12
SCHEMBL20008697 0.75 PRSS1 (0.52) TMPRSS15PRSS1TMPRSS2F2KLK1
SCHEMBL18720209 0.75 PRSS1 (0.52) TMPRSS15PRSS1TMPRSS2F2KLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180085366-A1 OPIOID COMPOSITIONS RESISTANT TO OVERDOSE AND ABUSE ELYSIUM THERAPEUTICS, INC. 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180085366-A1 OPIOID COMPOSITIONS RESISTANT TO OVERDOSE AND ABUSE OPRM1, OPRK1, OPRD1 TMPRSS15 87/4885PRSS1 952/4885TMPRSS2 588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.